Open Access
Table 2
Treatment received by real-world patients prior to treatment with the TheraBionic device. The Table reports the number of patients who received systemic and locoregional treatments prior to treatment with the TheraBionic device.
| Prior treatments | Total |
|---|---|
| Sorafenib | 13 |
| Chemoembolization | 9 |
| Hepatectomy | 2 |
| Nivolumab | 2 |
| Radiofrequency ablation | 2 |
| Sunitinib | 1 |
| SIR-spheres | 1 |
| Lenvatinib | 1 |
| Stereotactic Body Radiation Therapy | 1 |
| Regorafenib | 1 |
| Atezolizumab plus Bevacizumab | 1 |
| Ytrium-90 radioembolization | 1 |
| Cryoablation | 1 |
| Pancreatectomy | 1 |
| Splenectomy | 1 |
| No prior treatment | 1 |